Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Thu, 08/9/18 - 08:46 pm
Tags:
Iraq, DOJ, AstraZeneca, Roche, JNJ, GE, Pfizer
Pharma watchers on Twitter chat up Johnson & Johnson Xarelto TV ad that seems 'misleading'
Fierce Pharma
Thu, 08/9/18 - 08:44 pm
Tags:
JNJ, Xarelto, drug ads, twitter, social media
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
Fierce Pharma
Thu, 08/9/18 - 08:05 am
Tags:
JNJ, Pharma CEOs, Alex Gorsky, Donald Trump, drug pricing
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Wed, 08/1/18 - 11:33 pm
Tags:
Pfizer, Celltrion, JNJ, Janssen, patents, Remicade
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Mon, 07/30/18 - 11:45 am
Tags:
Pfizer, Bristol-Myers Squibb, JNJ, Eliquis, Xarelto, Warfarin, bloodthinners
Johnson & Johnson wins $227m DoD spinal implant supply contract
Mass Device
Fri, 07/27/18 - 07:07 pm
Tags:
JNJ, defense contracts, devices, spinal implants
Artificial hip maker demands retraction of a paper calling its research ‘grave fraudulence’
Stat
Fri, 07/27/18 - 10:33 am
Tags:
JNJ, DePuy, Pinnacle Hip, devices
J&J, UPenn announce launch of Philly JLabs healthcare incubator
Mass Device
Sat, 07/21/18 - 12:09 am
Tags:
JNJ, innovation, U Penn, Philadelphia
[video+transcript]These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories
Motley Fool
Thu, 07/19/18 - 09:09 pm
Tags:
earnings, Unitedhealth Group, JNJ
Where does J&J's new drug fit in the crowded HIV market?
Biopharma Dive
Wed, 07/18/18 - 09:54 pm
Tags:
JNJ, Janssen, FDA, HIV, Symtuza
Johnson & Johnson beats revenue, profit projections for 2Q
Yahoo/AP
Tue, 07/17/18 - 09:45 am
Tags:
JNJ, earnings
J&J declares a historic success as Invokana comes through in PhIII chronic kidney disease trial
Endpoints
Mon, 07/16/18 - 10:24 pm
Tags:
JNJ, Invokana, chronic kidney disease
J&J taps German Merck to market Invokana in China
Biopharma Dive
Fri, 07/13/18 - 11:04 pm
Tags:
JNJ, Xian-Janssen, Merck KGaA, Invokana, China
Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case
TheStreet.com
Fri, 07/13/18 - 09:38 am
Tags:
JNJ, ovarian cancer
Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more
Endpoints
Thu, 07/12/18 - 06:27 pm
Tags:
Genmab, JNJ, Europe, cancer immunotherapy, Immatics
J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?
Yahoo/Zacks.com
Thu, 07/12/18 - 11:52 am
Tags:
JNJ, earnings
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
Tags:
JNJ, Tremfya, MorphoSys, Janssen, Crohn's Disease, clinical trials
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
Tags:
M&A, biotech, Celgene, Sanofi, Impact Biomedicines, Bioverativ, GSK, Takeda, Shire, JNJ
Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest
Endpoints
Thu, 07/5/18 - 11:22 am
Tags:
Donald Trump, UK, Brexit, JNJ, GSK, Pharma CEOs, Alex Gorsky, Emma Walmsley
J&J scores third appeals win—this one for $55M—in talc powder litigation
Fierce Pharma
Tue, 07/3/18 - 10:13 am
Tags:
JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.